RARE
Ultragenyx Pharmaceutical Inc. Earnings
$42.59
Earnings Summary
Revenue | $164.88Mn |
Net Profits | $-133.39Mn |
Net Profit Margins | -80.9% |
Ultragenyx Pharmaceutical Inc.’s revenue jumped 29.42% since last year same period to $164.88Mn in the Q4 2024. On a quarterly growth basis, Ultragenyx Pharmaceutical Inc. has generated 18.2% jump in its revenue since last 3-months.
Ultragenyx Pharmaceutical Inc.’s net profit fell -8.28% since last year same period to $-133.39Mn in the Q4 2024. On a quarterly growth basis, Ultragenyx Pharmaceutical Inc. has generated 0.1% jump in its net profits since last 3-months.
Ultragenyx Pharmaceutical Inc.’s net profit margin jumped 16.34% since last year same period to -80.9% in the Q4 2024. On a quarterly growth basis, Ultragenyx Pharmaceutical Inc. has generated 15.48% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -1.75 |
EPS Estimate Current Year | -1.75 |
Ultragenyx Pharmaceutical Inc.’s earning per share (EPS) estimates for the current quarter stand at -1.75 - a -37.8% fall from last quarter’s estimates.
Ultragenyx Pharmaceutical Inc.’s earning per share (EPS) estimates for the current year stand at -1.75.
Key Ratios
Earning Per Share (EPS) | -1.39 |
Ultragenyx Pharmaceutical Inc.’s earning per share (EPS) jumped 8.55% since last year same period to -1.39 in the Q4 2024. This indicates that the Ultragenyx Pharmaceutical Inc. has generated 8.55% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-05-03 | -1.73 | -2.03 | -17.34% |
2024-08-02 | -1.69 | -1.52 | 10.06% |
2024-11-06 | -1.45 | -1.4 | 3.45% |
